IMU is sure doing some volume.
A string of new appointments suggests things are really building and i wouldn't be at all surprised to see a tipsheet or two emerge.
The trial itself will take approx until the end of the year, so it's difficult to say how/when the stock will re-rate; hopefully something similar to OPT.
Add to My Watchlist
What is My Watchlist?